Market Research Reports and Industry Reports

Cell-based Assays Market by Product (Cell Lines, Reagents, Kits, Instruments, Software, Services), Applications (Research, Drug Discovery, ADME Studies, Toxicology), End User (Pharmaceutical Companies, Academics, CRO), & Region - Global Forecast to 2020

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

The global cell-based assays market is expected to reach USD 18,329.37 million by 2020 from USD 10,799.53 million in 2015, growing at a CAGR of 11.16% between 2015 and 2020. The product segments included in this report are consumables, instruments, services and software. The consumables segment is further divided on the basis of type into reagents and assay kits, cell lines, micro plates. Reagents and assay kits segment is further divided into reporter gene assays, second messenger assays, cell growth assays, cell death assays and other assays. Cell lines segment is further classified into immortalized cell lines, primary cell lines and stem cell lines. On the basis of applications; the report is segmented into basic research, drug discovery, predictive toxicology, ADME studies and other applications. The drug discovery had the largest share of the cell-based assays market in 2015. The predictive toxicology is expected to be one of the fastest growing applications between 2015 and 2020.
 
 The geographic segments included in this report are North America, Europe, Asia and Rest of the World (RoW). The geographic analysis reveals that North America accounted for the largest share in the global cell-based assays market in 2015. Asia regional segment, on the other hand, is expected to register a faster growth from 2015 to 2020.
 
 The key driver for this market is increased R&D spending on research. Furthermore, growing benefits of cell-based assays over other methods, their increasing adoption in drug discovery, and advancements in automation and high-throughput techniques will aid market growth.
 
 A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global cell-based assays market and its sub-segments. Secondary information was used to identify the overall revenues, geographic reach, and product portfolios of the market players. Estimates of their cell-based assays product segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine percentage shares of each sub segment and the relative differences in the growth rates.
 
 The report provides qualitative insights about key market shares, growth rates, and market drivers for all important sub segments. It maps the market sizes and growth rates of each sub segment and identifies the segments poised for rapid growth in each of the geographic segments. The report also includes company profiles of the market leaders. These company profiles include financial performances, product portfolios, and market developments for each company. The report also provides a competitive landscape of the cell-based assays market. The competitive landscape covers the growth strategies adopted by the industry players over the last four years. It also includes analysis of industry developments like new product launches, expansions, agreements and collaborations and acquisitions.
 
 Reasons to Buy the Report:
 
 The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.
 
 The report provides insights on the following:
 
 • Product Development: Product portfolios of the top players in the cell-based assays market.
 • Competitive Assessment: In-depth assessment of the market shares, strategies, geographic and business segments, and product portfolios of the leading players in the cell-based assays market.
 • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the market for various cell-based assays products across geographies.

1 INTRODUCTION 16
 1.1 OBJECTIVES OF THE STUDY 16
 1.2 MARKET DEFINITION 16
 1.3 MARKET SCOPE 17
 1.3.1 MARKETS COVERED 17
 1.3.2 YEARS CONSIDERED FOR THE STUDY 17
 1.4 CURRENCY 18
 1.5 LIMITATIONS 18
 1.6 STAKEHOLDERS 18
 2 RESEARCH METHODOLOGY 19
 2.1 MARKET SIZE ESTIMATION 20
 2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 22
 2.3 MARKET SHARE ESTIMATION 24
 2.3.1 KEY DATA FROM SECONDARY SOURCES 24
 2.3.2 KEY DATA FROM PRIMARY SOURCES 24
 2.3.3 ASSUMPTIONS FOR THE STUDY 25
 3 EXECUTIVE SUMMARY 26
 4 PREMIUM INSIGHTS 32
 4.1 LUCRATIVE OPPORTUNITIES IN THE CELL-BASED ASSAYS MARKET 32
 4.2 LIFE CYCLE ANALYSIS, BY REGION 35
 5 MARKET OVERVIEW 36
 5.1 INTRODUCTION 37
 5.1.1 BY PRODUCT 37
 5.1.2 BY APPLICATION 38
 5.1.3 BY END USER 38
 5.2 MARKET DYNAMICS 39
 5.2.1 DRIVERS 40
 5.2.1.1 Increase in R&D investments 40
 5.2.1.2 Government funding and public-private partnerships supporting cell-based research activities 40
 5.2.1.3 Advantages of cell-based assays over prevalent technologies 41
 5.2.1.4 Drug discovery, a major driver for the cell-based assays market 41
  
 5.2.2 RESTRAINTS 42
 5.2.2.1 High instrument costs 42
 5.2.2.2 Stringent regulatory policies 42
 5.2.2.3 Intellectual property rights issues restricting innovations in the market 42
 5.2.3 OPPORTUNITIES 43
 5.2.3.1 Asian region offers high-growth opportunities 43
 5.2.3.2 Developments in high-content screening and software to transform cell-based screening 44
 5.2.4 TRENDS 45
 5.2.4.1 Label-free technologies are set to transform the market 45
 6 CELL-BASED ASSAYS MARKET, BY PRODUCT 46
 6.1 INTRODUCTION 47
 6.2 CONSUMABLES 49
 6.2.1 REAGENTS & ASSAY KITS 51
 6.2.1.1 Reporter gene assays 53
 6.2.1.2 Second messenger assays 54
 6.2.1.3 Cell growth assays 55
 6.2.1.4 Cell death assays 56
 6.2.1.5 Other assays 57
 6.2.2 MICROPLATES 58
 6.2.3 CELL LINES 59
 6.2.3.1 Immortalized cell lines 60
 6.2.3.2 Primary cell lines 61
 6.2.3.3 Stem cell lines 62
 6.2.4 OTHER CONSUMABLES 63
 6.3 INSTRUMENTS 64
 6.4 SERVICES 66
 6.5 SOFTWARE 68
 7 CELL-BASED ASSAYS MARKET, BY APPLICATION 70
 7.1 INTRODUCTION 71
 7.2 DRUG DISCOVERY 72
 7.3 BASIC RESEARCH 74
 7.4 ADME STUDIES 75
 7.5 PREDICTIVE TOXICOLOGY 77
 7.6 OTHER APPLICATIONS 78
  
 8 CELL-BASED ASSAYS MARKET, BY END USER 80
 8.1 INTRODUCTION 81
 8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 82
 8.3 ACADEMIC & GOVERNMENT INSTITUTIONS 84
 8.4 CONTRACT RESEARCH ORGANIZATIONS 85
 8.5 OTHER END USERS 87
 9 CELL-BASED ASSAYS MARKET, BY REGION 89
 9.1 INTRODUCTION 90
 9.2 NORTH AMERICA 93
 9.2.1 U.S. 101
 9.2.2 CANADA 106
 9.3 EUROPE 112
 9.4 ASIA 117
 9.5 REST OF THE WORLD (ROW) 124
 10 COMPETITIVE LANDSCAPE 130
 10.1 INTRODUCTION 130
 10.2 STRATEGIC OVERVIEW 130
 10.3 MARKET SHARE ANALYSIS 131
 10.4 COMPETITIVE SITUATION AND TRENDS 132
 10.4.1 NEW PRODUCT LAUNCHES 133
 10.4.2 ACQUISITIONS 134
 10.4.3 COLLABORATIONS AND AGREEMENTS 135
 10.4.4 EXPANSIONS 136
 10.4.5 OTHER DEVELOPMENTS 136
 11 COMPANY PROFILES 137
 (Overview, Products and Services, Financials, Strategy & Development)*
 11.1 INTRODUCTION 137
 11.2 BECTON, DICKINSON AND COMPANY 138
 11.3 CELL SIGNALING TECHNOLOGY, INC. 142
 11.4 CISBIO BIOASSAYS 144
 11.5 DANAHER CORPORATION 148
 11.6 DISCOVERX CORPORATION 152
 11.7 GENERAL ELECTRIC COMPANY 154
 11.8 MERCK KGAA 157
 11.9 PERKINELMER, INC. 160
  
 11.10 PROMEGA CORPORATION 164
 11.11 THERMO FISHER SCIENTIFIC, INC. 166
 *Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.
 12 APPENDIX 170
 12.1 INSIGHTS OF INDUSTRY EXPERTS 170
 12.2 DISCUSSION GUIDE 171
 12.3 OTHER DEVELOPMENTS 174
 12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 175
 12.5 AVAILABLE CUSTOMIZATIONS 177
 12.6 RELATED REPORTS 178


List Of Tables

 TABLE 1 CELL-BASED ASSAYS MARKET SUMMARY 26
 TABLE 2 INCREASING HEALTHCARE EXPENDITURE: THE PRIMARY DRIVER FOR
 THE GROWTH OF THE CELL-BASED ASSAYS MARKET 41
 TABLE 3 MARKET GROWTH RESTRAINED BY HIGH INSTRUMENT COSTS 43
 TABLE 4 EMERGING ECONOMIES PRESENT SIGNIFICANT GROWTH OPPORTUNITIES 45
 TABLE 5 LABEL-FREE TECHNOLOGIES ARE AN IMPORTANT MARKET TREND 45
 TABLE 6 CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION) 48
 TABLE 7 CELL-BASED ASSAYS MARKET SIZE FOR CONSUMABLES, BY REGION,
 2013–2020 (USD MILLION) 50
 TABLE 8 CELL-BASED ASSAYS MARKET SIZE FOR CONSUMABLES, BY TYPE,
 2013–2020 (USD MILLION) 51
 TABLE 9 CELL-BASED ASSAYS MARKET SIZE FOR REAGENTS & ASSAY KITS, BY REGION, 2013–2020 (USD MILLION) 52
 TABLE 10 CELL-BASED ASSAYS MARKET FOR REAGENTS & ASSAY KITS, BY TYPE,
 2013–2020 (USD MILLION) 53
 TABLE 11 CELL-BASED ASSAYS MARKET SIZE FOR REPORTER GENE ASSAYS, BY REGION, 2013–2020 (USD MILLION) 54
 TABLE 12 CELL-BASED ASSAYS MARKET SIZE FOR SECOND MESSENGER ASSAYS,
 BY REGION, 2013–2020 (USD MILLION) 55
 TABLE 13 CELL-BASED ASSAYS MARKET SIZE FOR CELL GROWTH ASSAYS, BY REGION, 2013–2020 (USD MILLION) 56
 TABLE 14 CELL-BASED ASSAYS MARKET SIZE FOR CELL DEATH ASSAYS, BY REGION,
 2013–2020 (USD MILLION) 57
 TABLE 15 CELL-BASED ASSAYS MARKET SIZE FOR OTHER ASSAYS, BY REGION,
 2013–2020 (USD MILLION) 58
 TABLE 16 CELL-BASED ASSAYS MARKET SIZE FOR MICROPLATES, BY REGION,
 2013–2020 (USD MILLION) 59
 TABLE 17 CELL-BASED ASSAYS MARKET SIZE FOR CELL LINES, BY REGION,
 2013–2020 (USD MILLION) 60
 TABLE 18 CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE,
 2013–2020 (USD MILLION) 60
 TABLE 19 CELL-BASED ASSAYS MARKET SIZE FOR IMMORTALIZED CELL LINES, BY REGION, 2013–2020 (USD MILLION) 61
 TABLE 20 CELL-BASED ASSAYS MARKET SIZE FOR PRIMARY CELL LINES, BY REGION,
 2013–2020 (USD MILLION) 62
 TABLE 21 CELL-BASED ASSAYS MARKET SIZE FOR STEM CELL LINES, BY REGION,
 2013–2020 (USD MILLION) 63
 TABLE 22 CELL-BASED ASSAYS MARKET SIZE FOR OTHER CONSUMABLES, BY REGION, 2013–2020 (USD MILLION) 64
 TABLE 23 CELL-BASED ASSAYS MARKET SIZE FOR INSTRUMENTS, BY REGION,
 2013–2020 (USD MILLION) 65
 TABLE 24 CELL-BASED ASSAYS MARKET SIZE FOR SERVICES, BY REGION,
 2013–2020 (USD MILLION) 67
 TABLE 25 CELL-BASED ASSAYS MARKET SIZE FOR SOFTWARE, BY REGION,
 2013–2020 (USD MILLION) 69
 TABLE 26 CELL-BASED ASSAYS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION) 72
 TABLE 27 CELL-BASED ASSAYS MARKET SIZE FOR DRUG DISCOVERY APPLICATION,
 BY REGION, 2013–2020 (USD MILLION) 73
 TABLE 28 CELL-BASED ASSAYS MARKET SIZE FOR BASIC RESEARCH APPLICATION,
 BY REGION, 2013–2020 (USD MILLION) 75
 TABLE 29 CELL-BASED ASSAYS MARKET SIZE FOR ADME STUDIES APPLICATION, BY REGION, 2013–2020 (USD MILLION) 76
 TABLE 30 CELL-BASED ASSAYS MARKET SIZE FOR PREDICTIVE TOXICOLOGY APPLICATION, BY REGION, 2013–2020 (USD MILLION) 78
 TABLE 31 CELL-BASED ASSAYS MARKET SIZE FOR OTHER APPLICATIONS, BY REGION,
 2013–2020 (USD MILLION) 79
 TABLE 32 CELL-BASED ASSAYS MARKET SIZE, BY END USER, 2013–2020 (USD MILLION) 82
 TABLE 33 CELL-BASED ASSAYS MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2013–2020 (USD MILLION) 83
 TABLE 34 CELL-BASED ASSAYS MARKET SIZE FOR ACADEMIC & GOVERNMENT INSTITUTIONS, BY REGION, 2013–2020 (USD MILLION) 85
 TABLE 35 CELL-BASED ASSAYS MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2013–2020 (USD MILLION) 86
 TABLE 36 CELL-BASED ASSAYS MARKET SIZE FOR OTHER END USERS, BY REGION,
 2013–2020 (USD MILLION) 88
 TABLE 37 CELL-BASED ASSAYS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 92
 TABLE 38 NORTH AMERICA: CELL-BASED ASSAYS MARKET SIZE, BY COUNTRY,
 2013–2020 (USD MILLION) 95
 TABLE 39 NORTH AMERICA: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT,
 2013–2020 (USD MILLION) 96
 TABLE 40 NORTH AMERICA: CELL-BASED ASSAYS MARKET SIZE FOR CONSUMABLES,
 BY TYPE, 2013–2020 (USD MILLION) 97
 TABLE 41 NORTH AMERICA: CELL-BASED ASSAYS MARKET SIZE FOR REAGENTS
 & ASSAY KITS, BY TYPE, 2013–2020 (USD MILLION) 98
 TABLE 42 NORTH AMERICA: CELL-BASED ASSAYS MARKET SIZE, BY APPLICATION,
 2013–2020 (USD MILLION) 99
 TABLE 43 NORTH AMERICA: CELL-BASED ASSAYS MARKET SIZE, BY END USER,
 2013–2020 (USD MILLION) 100
 TABLE 44 U.S.: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT,
 2013–2020 (USD MILLION) 102
 TABLE 45 U.S.: CELL-BASED ASSAYS MARKET SIZE FOR CONSUMABLES, BY TYPE,
 2013–2020 (USD MILLION) 103
 TABLE 46 U.S.: CELL-BASED ASSAYS MARKET SIZE FOR REAGENTS & ASSAY KITS, BY TYPE, 2013–2020 (USD MILLION) 104
 TABLE 47 U.S.: CELL-BASED ASSAYS MARKET SIZE, BY APPLICATION,
 2013–2020 (USD MILLION) 105
 TABLE 48 U.S.: CELL-BASED ASSAYS MARKET SIZE, BY END USER,
 2013–2020 (USD MILLION) 106
 TABLE 49 CANADA: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT,
 2013–2020 (USD MILLION) 107
 TABLE 50 CANADA: CELL-BASED ASSAYS MARKET SIZE FOR CONSUMABLES, BY TYPE,
 2013–2020 (USD MILLION) 108
 TABLE 51 CANADA: CELL-BASED ASSAYS MARKET SIZE FOR REAGENTS & ASSAY KITS,
 BY TYPE, 2013–2020 (USD MILLION) 109
 TABLE 52 CANADA: CELL-BASED ASSAYS MARKET SIZE, BY APPLICATION,
 2013–2020 (USD MILLION) 110
 TABLE 53 CANADA: CELL-BASED ASSAYS MARKET SIZE, BY END USER,
 2013–2020 (USD MILLION) 111
 TABLE 54 EUROPE: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT,
 2013–2020 (USD MILLION) 113
 TABLE 55 EUROPE: CELL-BASED ASSAYS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013–2020 (USD MILLION) 114
 TABLE 56 EUROPE: CELL-BASED ASSAYS MARKET FOR REAGENTS & ASSAY KITS, BY TYPE, 2013–2020 (USD MILLION) 115
 TABLE 57 EUROPE: CELL-BASED ASSAYS MARKET SIZE, BY APPLICATION,
 2013–2020 (USD MILLION) 116
 TABLE 58 EUROPE: CELL-BASED ASSAYS MARKET SIZE, BY END USER,
 2013–2020 (USD MILLION) 117
 TABLE 59 ASIA: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT,
 2013–2020 (USD MILLION) 119
 TABLE 60 ASIA: CELL-BASED ASSAYS MARKET SIZE FOR CONSUMABLES, BY TYPE,
 2013–2020 (USD MILLION) 120
 TABLE 61 ASIA: CELL-BASED ASSAYS MARKET SIZE FOR REAGENTS & ASSAY KITS, BY TYPE, 2013–2020 (USD MILLION) 121
 TABLE 62 ASIA: CELL-BASED ASSAYS MARKET SIZE, BY APPLICATION,
 2013–2020 (USD MILLION) 122
 TABLE 63 ASIA: CELL-BASED ASSAYS MARKET SIZE, BY END USER,
 2013–2020 (USD MILLION) 123
 TABLE 64 ROW: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT,
 2013–2020 (USD MILLION) 125
 TABLE 65 ROW: CELL-BASED ASSAYS MARKET SIZE FOR CONSUMABLES, BY TYPE,
 2013–2020 (USD MILLION) 126
 TABLE 66 ROW: CELL-BASED ASSAYS MARKET SIZE FOR REAGENTS & ASSAY KITS, BY TYPE, 2013–2020 (USD MILLION) 127
 TABLE 67 ROW: CELL-BASED ASSAYS MARKET SIZE, BY APPLICATION,
 2013–2020 (USD MILLION) 128
 TABLE 68 ROW: CELL-BASED ASSAYS MARKET SIZE, BY END USER,
 2013–2020 (USD MILLION) 129
 TABLE 69 MARKET DEVELOPMENTS BETWEEN JANUARY 2013 AND SEPTEMBER 2015 133
 TABLE 70 NEW PRODUCT LAUNCHES, JAUNARY 2013 TO SEPTEMBER 2015 133
 TABLE 71 ACQUISITIONS, JAUNARY 2013 TO SEPTEMBER 2015 134
 TABLE 72 COLLABORATIONS AND AGREEMENTS, JAUNARY 2013 TO SEPTEMBER 2015 135
 TABLE 73 EXPANSIONS, JAUNARY 2013 TO SEPTEMBER 2015 136
 TABLE 74 OTHER DEVELOPMENTS, JAUNARY 2013 TO SEPTEMBER 2015 136


List Of Figures

 FIGURE 1 CELL-BASED ASSAYS MARKET 17
 FIGURE 2 RESEARCH DESIGN 19
 FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 21
 FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 21
 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
 AND REGION 22
 FIGURE 6 DATA TRIANGULATION METHODOLOGY 23
 FIGURE 7 CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT, 2015 VS. 2020 (USD MILLION) 27
 FIGURE 8 CONSUMABLES MARKET SIZE, BY TYPE, 2015 VS. 2020 (USD MILLION) 28
 FIGURE 9 REAGENTS & KITS MARKET SIZE, BY TYPE, 2015 VS. 2020 (USD MILLION) 28
 FIGURE 10 CELL LINES MARKET SIZE, BY TYPE, 2015 VS. 2020 (USD MILLION) 29
 FIGURE 11 CELL-BASED ASSAYS MARKET SIZE, BY APPLICATION,
 2015 VS. 2020 (USD MILLION) 29
 FIGURE 12 CELL-BASED ASSAYS MARKET SIZE, BY END USER, 2015 VS. 2020 (USD MILLION) 30
 FIGURE 13 CELL-BASED ASSAYS MARKET SIZE, BY REGION, 2015 VS. 2020 (USD MILLION) 31
 FIGURE 14 GLOBAL CELL-BASED ASSAYS MARKET TO WITNESS MODERATE GROWTH DURING THE FORECAST PERIOD 32
 FIGURE 15 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES END-USER SEGMENT TO DOMINATE THE CELL-BASED ASSAYS MARKET 33
 FIGURE 16 ASIA TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 34
 FIGURE 17 ASIAN MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES 35
 FIGURE 18 CELL-BASED ASSAYS MARKET SEGMENTATION: BY PRODUCT 37
 FIGURE 19 CELL-BASED ASSAYS MARKET SEGMENTATION: BY APPLICATION 38
 FIGURE 20 CELL-BASED ASSAYS MARKET SEGMENTATION: BY END USER 38
 FIGURE 21 INCREASING R&D SPENDING WILL DRIVE THE CELL-BASED ASSAYS MARKET DURING THE FORECAST PERIOD 39
 FIGURE 22 INCREASING R&D INVESTMENTS BOOSTING GROWTH IN
 THE CELL-BASED ASSAYS MARKET 44
 FIGURE 23 CELL-BASED ASSAYS MARKET SEGMENTATION, BY PRODUCT 47
 FIGURE 24 CELL-BASED ASSAYS MARKET, BY PRODUCT, 2015 (USD MILLION) 48
 FIGURE 25 NORTH AMERICA ACCOUNTS FOR THE LARGEST SHARE OF
 THE CONSUMABLES MARKET IN 2015 49
 FIGURE 26 CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE,
 2015 VS. 2020 (USD MILLION) 50
 FIGURE 27 CELL-BASED ASSAYS MARKET FOR REAGENTS & ASSAY KITS, BY TYPE,
 2015 VS. 2020 (USD MILLION) 52
 FIGURE 28 NORTH AMERICA ACCOUNTS FOR THE LARGEST SHARE OF THE INSTRUMENTS MARKET IN 2015 65
 FIGURE 29 NORTH AMERICA ACCOUNTS FOR THE LARGEST SHARE OF THE SERVICES MARKET IN 2015 67
 FIGURE 30 NORTH AMERICA ACCOUNTS FOR THE LARGEST SHARE OF
 THE SOFTWARE MARKET IN 2015 68
 FIGURE 31 CELL-BASED ASSAYS MARKET SEGMENTATION, BY APPLICATION 71
 FIGURE 32 DRUG DISCOVERY ACCOUNTS FOR THE LARGEST APPLICATION SEGMENT OF
 THE CELL-BASED ASSAYS MARKET IN 2015 71
 FIGURE 33 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF
 THE DRUG DISCOVERY APPLICATION SEGMENT IN 2015 73
 FIGURE 34 NORTH AMERICA TO DOMINATE THE CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATION IN 2015 74
 FIGURE 35 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF
 THE ADME STUDIES APPLICATION SEGMENT IN 2015 76
 FIGURE 36 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF
 THE PREDICTIVE TOXICOLOGY APPLICATION SEGMENT IN 2015 77
 FIGURE 37 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF
 THE OTHER APPLICATIONS SEGMENT IN 2015 79
 FIGURE 38 CELL-BASED ASSAYS MARKET SEGMENTATION, BY END USER 81
 FIGURE 39 CELL-BASED ASSAYS MARKET SIZE, BY END USER, 2015 (USD MILLION) 81
 FIGURE 40 NORTH AMERICA TO DOMINATE THE CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN 2015 83
 FIGURE 41 CELL-BASED ASSAYS MARKET FOR ACADEMIC & GOVERNMENT INSTITUTIONS TO WITNESS HIGHEST GROWTH IN ASIA BETWEEN 2015 AND 2020 84
 FIGURE 42 NORTH AMERICA TO DOMINATE THE CELL-BASED ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS BETWEEN 2015 AND 2020 86
 FIGURE 43 CELL-BASED ASSAYS MARKET FOR OTHER END USERS TO WITNESS HIGHEST GROWTH IN ASIA BETWEEN 2015 AND 2020 87
 FIGURE 44 ASIA TO GROW AT THE HIGHEST RATE IN THE CELL-BASED ASSAYS MARKET DURING THE FORECAST PERIOD 91
 FIGURE 45 GEOGRAPHIC SNAPSHOT (2015) 92
 FIGURE 46 NORTH AMERICA: MARKET SNAPSHOT 94
 FIGURE 47 THE U.S. IS ESTIMATED TO DOMINATE THE NORTH AMERICAN CELL-BASED ASSAYS MARKET IN 2015 95
 FIGURE 48 CONSUMABLES ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN
 THE NORTH AMERICAN CELL-BASED ASSAYS MARKET IN 2015 96
 FIGURE 49 REAGENTS & ASSAY KITS ESTIMATED TO BE THE LARGEST SEGMENT IN
 THE NORTH AMERICAN CONSUMABLES MARKET IN 2015 97
 FIGURE 50 REPORTER GENE ASSAYS ESTIMATED TO BE THE LARGEST SEGMENT IN
 THE NORTH AMERICAN REAGENTS & ASSAY KITS MARKET IN 2015 98
 FIGURE 51 DRUG DISCOVERY TO ACCOUNT FOR THE LARGEST SHARE OF
 THE APPLICATION MARKET IN NORTH AMERICA IN 2015 99
 FIGURE 52 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR
 THE LARGEST SHARE OF THE END-USER MARKET IN NORTH AMERICA 100
 FIGURE 53 CONSUMABLES ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN
 THE U.S. CELL-BASED ASSAYS MARKET IN 2015 101
 FIGURE 54 REAGENTS & ASSAY KITS ESTIMATED TO BE THE LARGEST SEGMENT IN
 THE U.S. CONSUMABLES MARKET IN 2015 102
 FIGURE 55 REPORTER GENE ASSAYS ESTIMATED TO BE THE LARGEST SEGMENT IN
 THE U.S. REAGENTS & ASSAY KITS MARKET IN 2015 103
 FIGURE 56 DRUG DISCOVERY TO ACCOUNT FOR THE LARGEST APPLICATION OF
 THE U.S. CELL-BASED ASSAYS MARKET IN 2015 104
 FIGURE 57 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR
 THE LARGEST SHARE OF THE END-USER MARKET IN THE U.S. 105
 FIGURE 58 CONSUMABLES ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN
 THE CELL-BASED ASSAYS MARKET IN CANADA IN 2015 107
 FIGURE 59 REAGENTS & ASSAYS KITS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE CONSUMABLES MARKET IN CANADA IN 2015 108
 FIGURE 60 REPORTER GENE ASSAYS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE REAGENTS & ASSAY KITS MARKET IN CANADA IN 2015 109
 FIGURE 61 DRUG DISCOVERY TO ACCOUNT FOR THE LARGEST APPLICATION OF
 THE CELL-BASED ASSAYS MARKET IN CANADA IN 2015 110
 FIGURE 62 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR
 THE LARGEST SHARE OF THE END-USER MARKET IN CANADA 111
 FIGURE 63 CONSUMABLES ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN
 THE EUROPEAN CELL-BASED ASSAYS MARKET IN 2015 112
 FIGURE 64 REAGENTS & ASSAY KITS ESTIMATED TO BE THE LARGEST SEGMENT IN
 THE EUROPEAN CONSUMABLES MARKET IN 2015 113
 FIGURE 65 REPORTER GENE ASSAYS ESTIMATED TO BE THE LARGEST SEGMENT IN
 THE EUROPEAN REAGENTS & ASSAY KITS MARKET IN 2015 114
 FIGURE 66 DRUG DISCOVERY TO ACCOUNT FOR THE LARGEST SHARE OF
 THE CELL-BASED ASSAYS APPLICATION MARKET IN EUROPE IN 2015 115
 FIGURE 67 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR
 THE LARGEST SHARE OF THE CELL-BASED ASSAYS END-USER MARKET IN EUROPE 116
 FIGURE 68 ASIA: MARKET SNAPSHOT 118
 FIGURE 69 CONSUMABLES ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN
 THE ASIAN MARKET IN 2015 119
 FIGURE 70 REAGENTS & ASSAY KITS ESTIMATED TO BE THE LARGEST SEGMENT IN
 THE ASIAN CONSUMABLES MARKET IN 2015 120
 FIGURE 71 REPORTER GENE ASSAYS ESTIMATED TO BE THE LARGEST SEGMENT IN
 THE ASIAN REAGENTS & ASSAY KITS MARKET IN 2015 121
 FIGURE 72 DRUG DISCOVERY TO ACCOUNT FOR THE LARGEST SHARE OF
 THE CELL-BASED ASSAYS APPLICATIONS MARKET IN ASIA IN 2015 122
 FIGURE 73 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR
 THE LARGEST SHARE OF THE CELL-BASED ASSAYS END-USER MARKET IN ASIA 123
 FIGURE 74 CONSUMABLES ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN
 THE ROW CELL-BASED ASSAYS MARKET IN 2015 124
 FIGURE 75 REAGENTS & ASSAY KITS ESTIMATED TO BE THE LARGEST SEGMENT IN
 THE ROW CONSUMABLES MARKET IN 2015 125
 FIGURE 76 REPORTER GENE ASSAYS ESTIMATED TO BE THE LARGEST SEGMENT IN
 THE ROW REAGENTS & ASSAY KITS MARKET IN 2015 126
 FIGURE 77 DRUG DISCOVERY TO ACCOUNT FOR THE LARGEST SHARE OF
 THE ROW CELL-BASED ASSAYS APPLICATIONS MARKET IN 2015 127
 FIGURE 78 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR
 THE LARGEST SHARE OF THE ROW CELL-BASED ASSAYS END-USER MARKET 128
 FIGURE 79 NEW PRODUCTS LAUNCHES IS THE KEY GROWTH STRATEGY ADOPTED
 BY PLAYERS IN THE CELL-BASED ASSAYS MARKET 130
 FIGURE 80 CELL-BASED ASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015 131
 FIGURE 81 FINANCIAL PERFORMANCES OF THE LEADING MARKET PLAYERS 137
 FIGURE 82 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 138
 FIGURE 83 DANAHER CORPORATION: COMPANY SNAPSHOT 148
 FIGURE 84 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT 154
 FIGURE 85 MERCK KGAA: COMPANY SNAPSHOT 157
 FIGURE 86 PERKINELMER, INC.: COMPANY SNAPSHOT 160
 FIGURE 87 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT 166


Cell-based Assays Market by Product (Cell Lines, Reagents, Kits, Instruments, Software, Services), Applications (Research, Drug Discovery, ADME Studies, Toxicology), End User (Pharmaceutical Companies, Academics, CRO), & Region - Global Forecast to 2020

The global cell-based assays market is expected to reach USD 18,329.37 million by 2020 from USD 10,799.53 million in 2015, growing at a CAGR of 11.16% between 2015 and 2020.

USD 5650View Report

USD 5650View Report

Global Cell-based Assays Consumption 2016 Market Research Report

The Global Cell-based Assays Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Cell-based Assays market.First, the report provides a basic overview

USD 4000View Report

United States Molecular Assays Market Report 2016

NotesSales, means the sales volume of Molecular AssaysRevenue, means the sales value of Molecular AssaysThis report studies sales (consumption) of Molecular Assays in United States market, focuses on the top

USD 3800View Report

Global Molecular Assays Market Research Report 2016

Notes:Production, means the output of Molecular AssaysRevenue, means the sales value of Molecular AssaysThis report studies Molecular Assays in Global market, especially in North America, Europe, China, Japan, Southeast Asia

USD 2900View Report

Europe Labeling and Linkage Agents for Immunoassays Market Report 2021

This report studies sales (consumption) of Labeling and Linkage Agents for Immunoassays in Europe market, especially in Germany, UK, France, Italy, Spain and Russia, focuses on top players in these

USD 4900View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

Discount on PDF and Enterprise Wide Licence reports
  • PDF $ 5650    $ 5650
  • Multi User Licence $ 6650    $ 6650
  • Corporate Licence $ 8150    $ 8150
  • Enterprise Wide Licence $ 10000    $ 10000
$ 5650

Reports Details

Published Date : Nov 2015
No. of Pages :179
Country :Global
Category :Healthcare
Publisher :MarketsandMarkets
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment